Latest News

Registration Now Open for the 2020 Virtual SMA Conference

May 27, 2020
Posted in ,

Cure SMA has released the agenda and registration details for the 2020 Virtual SMA Conference, which will be held from Monday, June 8th – Friday, June 12th. We greatly look […]

Read More ›

Biogen Shares SPINRAZA Research Update

May 18, 2020
Posted in ,

New SPINRAZA® (nusinersen) Data Reinforce Sustained Efficacy and Longer-Term Safety Across Broad Range of SMA Patients Biogen Inc. recently announced additional data from the SPINRAZA (nusinersen) clinical development program that […]

Read More ›

Cure SMA Announces a 2020 Virtual SMA Conference – United, At Home

May 14, 2020
Posted in ,

Cure SMA has been hosting the Annual SMA Conference since 1988, bringing together leading researchers, clinicians, affected individuals, and families living with SMA. The weekend has traditionally been filled with […]

Read More ›

Cure SMA Announces Summit of Strength Virtual Webinar Series

May 14, 2020
Posted in ,

For the past two years, Cure SMA’s Summit of Strength program has brought together thousands of SMA community members for the opportunity to network and learn about the latest advances […]

Read More ›

Biogen Releases Q2 Community Statement on Latest Milestones in Clinical Development Program

May 11, 2020
Posted in ,

Dear Members of the SMA Community, In light of the COVID-19 pandemic and the burden it has placed on our healthcare system, Biogen is working with health systems, institutions, physicians, […]

Read More ›

Update from Scholar Rock on TOPAZ Phase 2 Clinical Trial of SRK-015 in Patients with SMA

May 8, 2020
Posted in ,

Scholar Rock recently reported financial results for the first quarter ending March 31, 2020, highlighting progress and upcoming milestones for its pipeline programs—include the SRK-015 program for spinal muscular atrophy […]

Read More ›
Scroll to Top